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ABSTRACT: Tyrosine residues can act as redox cofactors
that provide an electron transfer (“hole-hopping”) route that
enhances the rate of ferryl heme iron reduction by externally
added reductants, for example, ascorbate. Aplysia fasciata
myoglobin, having no naturally occurring tyrosines but 15
phenylalanines that can be selectively mutated to tyrosine
residues, provides an ideal protein with which to study such
through-protein electron transfer pathways and ways to
manipulate them. Two surface exposed phenylalanines that
are close to the heme have been mutated to tyrosines (F42Y,
F98Y). In both of these, the rate of ferryl heme reduction
increased by up to 3 orders of magnitude. This result cannot be explained in terms of distance or redox potential change between
donor and acceptor but indicates that tyrosines, by virtue of their ability to form radicals, act as redox cofactors in a new pathway.
The mechanism is discussed in terms of the Marcus theory and the speciﬁc protonation/deprotonation states of the oxoferryl
iron and tyrosine. Tyrosine radicals have been observed and quantiﬁed by EPR spectroscopy in both mutants, consistent with the
proposed mechanism. The location of each radical is unambiguous and allows us to validate theoretical methods that assign
radical location on the basis of EPR hyperﬁne structure. Mutation to tyrosine decreases the lipid peroxidase activity of this
myoglobin in the presence of low concentrations of reductant, and the possibility of decreasing the intrinsic toxicity of
hemoglobin by introduction of these pathways is discussed.
1. INTRODUCTION
In a recent article, Gray and Winkler have reviewed electron
ﬂow through metalloproteins pointing out the role played by
certain aromatic amino acid residues (Tyr, Trp) that are
capable of acting as redox intermediates.1 An important issue
addressed by these authors is the mechanism through which
such amino acids may facilitate long distance electron transfer
though proteins between redox sites, making such transfers
much more rapid than would otherwise be the case considering
the distances between them. This mechanism depends on the
residues being capable of forming radicals in the redox potential
range normally available to biological reactions. By forming
such “electron conduits”, these amino acids act as way stations
for hole-hopping, equivalent to electron transfer. The rate of
electron ﬂow through proteins has previously been demon-
strated to be enhanced by addition of tryptophan residues to a
mutated form of azurin from Pseudomonas aeruginosa, in which
electron transfer between metal redox centers 19 Å apart was
increased by 2 orders of magnitude in a multistep electron
transfer pathway over that of a single-step pathway.2 Other
multistep electron transfer via an amino acid radical-hopping
pathway, spanning two protein subunits, has been observed
over distances of 35 Å in ribonucleotide reductase.3,4 Such
conduits can stem from a predominantly tyrosine-based transfer
pathway but may also include tryptophan and cysteine
residues,4,5 and a pure tryptophan conduit has also been
observed in DNA photolyase.6 Previously, we have described
results that show that tyrosine-based electron transfer pathways
may be introduced into hemoglobin (Hb) and myoglobin
(Mb), by mutating speciﬁc phenylalanine residues to tyrosine.
This mutation adds a single atom (oxygen) to the protein,
minimizing protein structural changes. It is, therefore, diﬃcult
to explain the dramatic increase in the rate of electron transfer
that is caused by introduction of a tyrosine except by reference
to the ability of this residue to access a radical state. In this
system, however, the apparent rate constant for electron
transfer, while increased, remains relatively low; we suggest that
electron transfer is limited by the very low concentrations of
the active species that are required to be present in deﬁned
states of protonation.7,8
To investigate further such tyrosine-based electron transfer
pathways and to explore how these may be manipulated, we
have used Mb from the sea slug Aplysia faciata (also known by
its junior synonym, Aplysia lamacina). Aplysia Mb has no
tyrosines but possesses 15 phenylalanine residues. This allows
the redox inactive phenylalanine residues to be selectively
changed to redox active tyrosines without extensive disturbance
of the protein tertiary structure. The V63H variant of the
protein was used to provide a distal histidine (often present in
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other globins such as human Mb and Hb), which assists in the
coordination of small molecules at the sixth position of the
heme and which acts as a proton donor/acceptor in the
mechanism of O−O bond scission in peroxides and hence the
formation of the oxyferryl heme species. This system can be
used as a test-bed for the investigation of electron movement
through the protein and associated migration of a radical
character in the opposite direction. By reacting the heme with
hydrogen peroxide, one may generate a stable oxyferryl species,
the kinetics of reduction to the ferric form of which one may
study spectroscopically. Because the ferryl form may access the
appropriate redox potential range, one can now explore the role
tyrosine residues in the electron transfer from reductants in the
medium to the buried heme group and the dependence of the
kinetics of reduction on the precise position of such tyrosines.
The tyrosine residues we have introduced (F42Y and F98Y) are
close to the heme pocket, but are also surface exposed and thus
positioned to allow them to act as redox cofactors between
exogenously added reductants and the heme iron. The results
show that the rate of the reduction of ferryl heme iron by
electron donating agents, such as ascorbate and hydro-
pyridinones, is increased in the presence of the tyrosine
electron pathways. This eﬀect is similar to that observed
previously for human Hb and sperm whale Mb; however, the
increase of the rate of ferryl reduction, consequent on tyrosine
introduction, was 2 orders of magnitude greater in Aplysia Mb
than that observed in human Hb and sperm whale Mb.9,10 We
also report that, although the oxidation of lipids by ferryl Mb is
relatively unchanged by the mutations, the addition of these
tyrosines signiﬁcantly protects lipids against oxidative damage,
in the presence of low concentrations of reductant. The
location of the tyrosine in relation to the heme and protein
surface is found to be critical in determining the kinetics of
electron transfer between exogenous reductants and the heme
iron.
One of the principal factors that has prevented acceptance of
hemoglobin-based oxygen carriers (HBOCs) in mainstream
medical care is a link to a signiﬁcantly increased risk of
myocardial infarction and mortality.11 One possible explanation
for this toxicity is the inherent ability of Hb to participate in
redox chemistry when outside its protected environment of the
red blood cell or following hypoxia-reoxygenation.12−14 The
ferryl oxidation state of Hb and various HBOCs have been
shown to facilitate oxidation of lipid membranes.15 Our data
strongly suggest that the introduction of tyrosine-based
electron transfer pathways partially detoxiﬁes Mb by inhibiting
oxidation of lipid membranes in the presence of low
concentrations of reductant. Thus, detoxifying the ferryl form,
by enhancing the reduction of ferryl heme iron by reductants
using these electron transfer pathways, could limit the oxidative
damage that HBOCs cause.
2. EXPERIMENTAL SECTION
2.1. Materials. Catalase, ascorbate, lipoxygenase, sodium phos-
phate, and asolectin were purchased from Sigma-Aldrich (Poole, UK).
Restriction enzymes were purchased from Fermentas (York, UK).
Mutation of the V63H protein to V63H/F42Y and V63H/F98Y was
achieved by using the QuikChange II site directed mutagenesis kit by
Stratagene (Agilent, Cheshire, UK), using primers from Fisher
Scientiﬁc (Loughborough, UK). CP20 (deferiprone, 1,2-dimethyl-3-
hydroxypyrid-4-one) was given by Prof. Robert Hider, Department of
Pharmacy, Kings College, London, UK.
2.2. Engineered Myoglobins. The gene for the V63H variant of
Mb from Aplysia faciata, contained in a pUC19 vector, was a kind gift
from Prof. Francesca Cutruzzola ̀ from the University of Rome, La
Sapienza. To facilitate puriﬁcation of the protein, a cleavable His-tag
was added via mutation of the 5′ end of the protein sequence to add a
FaqI restriction site and addition of an oligomer produced by Fischer
Scientiﬁc. The N terminal sequence of the unmodiﬁed Mb is
MetSerLeuSerAla−. Cleavage of the His-tag using thrombin
(−LeuValProArgGlySer−) leaves the serine of GlySer− as the ﬁrst
serine of the normal sequence (GlySerLeuSerAla−). To enhance
expression, the sequence was excised from the pUC19 vector (using
unique NcoI and SalI restriction sites) and transferred into a pET28a
vector with a T7 promoter. Vector was transformed into BL21 DE3
cells (Stratagene, UK) and added to Luria−Bertani medium, shaken at
120 rpm, 37 °C. When optical density at 600 nm was 0.5, isopropyl β-
D-1-thiogalactopyranoside was added (1 mM) with 5-aminoleuvelinc
acid (500 μM) and ferric citrate (100 μM) and incubated for a further
18−24 h. Cells were isolated by centrifugation (15 000g) and
mechanically disrupted using an Avestin Emulsiﬂex C5. His-tagged
Aplysia Mb (typically between 5 and 50 mg/L) was puriﬁed using a
nickel aﬃnity column (GE Healthcare, UK) as per manufacturer
instructions. Imidazole was removed through dialysis, and the tag was
cleaved through incubation with bovine thrombin (Sigma-Aldrich,
Poole, UK, 10U per mg protein). The thrombin cleavage of the his-tag
was exceptionally slow, probably due to the close proximity of the
cleavage site to the main α-helical globular structure of the protein, as
the protease recognition site included the ﬁrst two amino acids of the
protein tertiary structure. Therefore, the protein required incubation
for 5 days with thrombin at room temperature to induce suﬃcient
cleavage of the tag, incubated under sterile conditions to prevent
protein degradation. Tag-free protein was puriﬁed using the nickel
aﬃnity column, and the thrombin was separated from the myoglobin
by ﬁltration through a Vivascience vivaspin ﬁlter (30 kDa MWCO)
and concentrated using a vivaspin or vivacell ﬁlter (5 kDa MWCO).
Primers used were: 5′−3′ CCCGACTCTGCCAACTACTTCGCT-
GACTTCAAAGGC and GCCTTTGAAGTCAGCGAAG-
TAGTTGGCAGAGTCGGG for F42Y mutation and GCCAAGGAG-
CACGTAGGCTACGGTGTGGGATCTGCTCAA and TTGAGCA-
GATCCCACACCGTAGCCTACGTGCTCCTTGGC for F98Y
mutation. PCR products were transformed into competent XL 1Blue
cells (Stratagene) for ampliﬁcation and sequenced by GATC-biotech,
Germany.
2.3. Reduction Kinetics of Ferryl Aplysia Myoglobin. Ferryl
Mb was formed by the reaction of ferric Mb (10 μM) with excess
hydrogen peroxide (30 μM). The kinetics of ferryl formation was
monitored optically at 406 and 425 nm, and the time for optimum
ferryl formation was determined for each variant of Mb. When ferryl
formation was >95%, bovine catalase (20 nM) was added to remove
excess peroxide, and the reaction was allowed to proceed for further 1
min. Reductants ascorbate or CP20 (deferiprone) were mixed with the
ferryl protein at a 1:1 ratio, diluting the protein to a ﬁnal concentration
of 5 μM. The kinetics of ferryl reduction to the ferric oxidation state
was monitored optically using an Agilent 8453 diode array
spectrophotometer or an Applied Photophysics SX20 stopped ﬂow
spectrophotometer ﬁtted with a diode array detector. Rate constants
were determined by ﬁtting the time course (406−425 nm) to an
exponential function using the Microsoft Excel Solver algorithm (least
squared method) or using the Applied Photophysics ProK II program.
Single and double rectangular hyperbola ﬁts were obtained using the
Microsoft Excel Solver algorithm. Conﬁdence limits and R squared
values were calculated using Origin 8.0 by OriginLab.
2.4. Electron Paramagnetic Resonance Spectroscopy. EPR
samples of the proteins reacting with H2O2 were made by the rapid
freeze quenching (RFQ) method as previously described.16 All EPR
spectra were measured on a Bruker EMX EPR spectrometer (X-band)
at a modulation frequency of 100 kHz. A spherical high-quality Bruker
resonator SP9703 and an Oxford Instruments liquid helium system
were used to measure the low temperature EPR spectra. The EPR
spectra of the blank samples (frozen water) were subtracted from the
EPR spectra of the enzyme samples to eliminate the baseline caused by
the resonator’s walls, quartz insert, or quartz EPR tube.
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The g∥ = 2 component of the high spin (HS) ferric heme signal,
obtained from the Mb control samples (i.e., not mixed with H2O2), has
been subtracted from the EPR spectra of the protein radicals formed
under peroxide treatment with individual for each spectrum
coeﬃcients of subtraction as described elsewhere.17 Thus, the free
radical spectra presented in the Article are not contaminated with the
HS ferric heme EPR signal. The freeze-quenched control samples were
obtained by mixing a solution of Mb with a buﬀer in the freeze-quench
apparatus. To measure intensities of the EPR signals, the procedure of
spectra subtraction with a variable coeﬃcient was used.18 Because
diﬀerent EPR samples are measured at slightly diﬀerent microwave
frequencies, depending on the slight variation in the physical
characteristics of the EPR tubes, the same EPR signal in two diﬀerent
EPR samples can appear at slightly diﬀerent values of the magnetic
ﬁeld. To increase the accuracy of the spectra subtraction, this error has
been corrected by shifting each experimental spectrum to the left or to
the right along the magnetic ﬁeld in accordance with the diﬀerence
between the frequency used to record an individual spectrum and
some frequency value chosen as a standard for the whole array of
experimental spectra. Absolute concentration of free radicals was
determined by double integration of the EPR spectra measured at a
low microwave power and relating the integrals to that of a
concentration standard as described previously.17
Simulation of the EPR spectrum of the V63H/F42Y mutant treated
with H2O2 was performed using SimPow,
19 while the simulation
parameters were found by the Tyrosyl Radical Spectra Simulation
Algorithm (TRSSA),20 suggesting that the radical is on the introduced
Y42.
2.5. Lipid Oxidation Measurements. Liposomes were formed by
sonicating asolectin 50 mg/mL in 100 mM sodium phosphate buﬀer
containing 100 μM DTPA for 10 min. The asolectin was then forced
under pressure using pressurized nitrogen gas (∼20 bar) through a
Northern Lipids extruder as previously described.21 Liposomes (200
μg/mL) were incubated with myoglobin (1 μM) in 100 mM sodium
phosphate buﬀer containing 100 μM DTPA. UV and visible spectra
were monitored using an Agilent 8453 diode array spectrophotometer
ﬁtted with a multicell carriage. Kinetics of lipid conjugated diene
formation was followed at 234 nm, and the amount of conjugated
diene formed was calculated from a three-point baseline drop from
absorbance at 220 and 250 nm (Abs234 − (0.533 × Abs220 + 0.467 ×
Abs250)). The extinction coeﬃcient for conjugated diene at 234 nm
was 2.5 × 104 M−1 cm−122 as calculated from a known concentration of
13-S-hydroperoxy 9-cis, 11-trans octadecadienoic acid prepared from
the peroxidation of linoleic acid by soybean lipoxygenase,23 or 1.1 ×
104 M−1 cm−1 using the baseline drop method.
3. RESULTS
3.1. Tyrosine Redox Intermediates Facilitate Reduc-
tion of Ferryl Myoglobin. All three mutated forms of Aplysia
Mb (V63H, V63H/F42Y, V63H/F98Y), when reacted with
hydrogen peroxide, generate optical spectra indicative of ferryl
Mb. The kinetics of ferryl formation were not signiﬁcantly
diﬀerent for the proteins, although all three were faster when
compared to the wild type protein that lacked a distal histidine
residue.17 The stability of the ferryl form was diﬀerent in the
three variants as can be seen from diﬀerent rate constants for
the ferryl autoreduction to the ferric derivative (Table 1). The
presence of a tyrosine residue, either at position 42 or 98, had
an eﬀect of a signiﬁcant increase of the autoreduction rate (38-
or 69-fold, respectively). The autoreduction of the ferryl
proteins did not follow ﬁrst-order kinetics precisely, the time
courses being more complex than a single exponential function,
but were suﬃciently close to use as a comparison with the
pseudoﬁrst-order kinetics observed for the reduction of ferryl
Mb by ascorbate and CP20. The rate constant for
autoreduction of V63H ferryl ApMb (1.44 × 10−4 s−1) is
comparable to the previously reported autoreduction rate
constants under similar experimental conditions for horse heart
Mb (4.1 × 10−4 s−1) and human Hb β chain (3.0 × 10−4 s−1),
but lower than that for human Hb α chain (2.2 × 10−3 s−1).9,10
In these experiments, the radical produced concurrent with
ferryl formation was allowed to decay before reductant was
added. Therefore, all of our experiments on the reduction of
ferryl heme and the eﬀects of mutagenesis on this were
conducted after compound II is formed (no compound I can be
seen). A comparison of the time courses of the reduction of the
ferryl Aplysia Mb variants by 50 μM ascorbate is shown in
Figure 1, and the rate constants are summarized in Table 1.
The reduction of ferryl V63H Mb was slow, with a rate
constant of 1.65 × 10−3 s−1 at 50 μM ascorbate, giving a half-life
of 420 s. Under identical conditions, the reduction of ferryl
V63H/F42Y protein was much faster, with a rate constant of
reduction of 4.43 × 10−1 s−1, decreasing the half-life of the
ferryl species to 1.5 s. This was a 269-fold increase in reduction
rate as compared to the tyrosine-free V63H protein. The
V63H/F98Y Aplysia Mb ferryl reduction was characterized by a
rate constant of 1.95 s−1, further decreasing the half-life of the
Table 1. Kinetic Parameters of Ferryl Heme Autoreduction and Reduction by Ascorbate and CP20 in Aplysia Myoglobin V63H,
V63H/F42Y, and V63H/F98Y Mutantsa
protein
parameter V63H V63H/F42Y V63H/F98Y
Autoreduction
rate constant kobs (s
−1) 1.44 × 10−4± (2.56 × 10−6) 5.46 × 10−3± (4.04 × 10−5) 9.95 × 10−3± (1.82 × 10−5)
rate constant normalized to V63H 1 38 69
Ascorbate
rate constant kobs, 50 μM ascorbate (s
−1) 1.65 × 10−3± (1.25 × 10−5) 4.43 × 10−1± (2.48 × 10−2) 1.95 × 100± (1.46 × 10−2)
Rrate constant normalized to V63H 1 269 1180
KD for high aﬃnity pathway (μM) 1.8 ± 0.13 56.5 ± 5.93
kmax for high aﬃnity pathway (s
−1) 0 0.45 ± 0.04* 4.3 ± 0.30**
CP20
rate constant kobs, 50 μM CP20 (s
−1) 2.62 × 10−4± (1.58 × 10−6) 3.05 × 10−1± (5.10 × 10−3) 3.95 × 10−1± (7.75 × 10−3)
rate constant normalized to V63H 1 1166 1510
KD for high aﬃnity pathway (μM) 26.3 ± 2.55 514 ± 20.9
kmax for high aﬃnity pathway (s
−1) 0 0.45 ± 0.03* 4.2 ± 0.10**
aNote that the kmax for the V63H/F42Y protein (*) and the V63H/F98Y protein (**) are independent of reductant used. The errors in the values
determination were found from a nonlinear regression analysis at a 95% conﬁdence level.
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ferryl heme to 0.35 s. Thus reduction of the V63H/F98Y Mb
was 4.4-fold faster than the V63H/F42Y protein and 1180
times faster than the V63H protein. The reduction of ferryl
V63H/F98Y Mb was so rapid that measurement of the rate
constant could not be achieved accurately using standard
spectrophotometer techniques and was consequently measured
by a stopped ﬂow spectroscopy.
Figure 2A and B shows the ferryl Mb reduction rate
constants (pseudoﬁrst-order) as a function of ascorbate
concentration. Data points were ﬁtted to double rectangular
hyperbola functions (plus an oﬀset caused by autoreduction)
representing two distinct pathways for the reduction of the
ferryl heme by exogenous reductants:9,10
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where S is the substrate (ascorbate) concentration, kmax1 and
kmax2 are the maximum rate constants for electron transfer
between the reductant and heme iron via the two diﬀerent
pathways, KD1 and KD2 are the corresponding dissociation
constants of the two diﬀerent sites in Mb for reductant, and AR
represents the ferryl autoreduction rate constant. We have
previously shown that each hyperbola represents a distinct
pathway for the reduction of the ferryl heme by exogenous
reductants.9,10 One pathway is direct reduction of the ferryl
heme iron by the reductant. It is present in all three Aplysia
proteins examined and in the absence of the second pathway
produces the rate constant proﬁles that can be ﬁtted by a single
rectangular hyperbola function. The second pathway is the
through-protein electron transfer pathway, present in the
V63H/F42Y and V63H/F98Y proteins but not in V63H
protein. When a rate constant proﬁle is represented by a double
rectangular hyperbola function, it typically indicates the
presence of both the direct and the through-protein electron
transfer pathways.9 The direct reductant-to-heme-iron electron
transfer pathway (KD2) shows a very low aﬃnity for the
reductant with an apparent KD value typically in the high
millimolar range10 (not reported in this study due to uncertain
accuracy of its determination). The low aﬃnity pathway can be
observed with the reduction of ferryl V63H/F42Y protein by a
shallow increase in rate constant above 200 μM, where the
contribution by the high aﬃnity pathway ceases to signiﬁcantly
aﬀect the rate of ferryl reduction in both ascorbate and CP20
(Figure 2). Nonlinear regression analysis of the V63H/F42Y
ascorbate data yields an R2 value of 0.9656 when ﬁtted to a
single hyperbola and 0.9987 when ﬁtted to a double hyperbola,
showing that a two-pathway mechanism is required to more
accurately describe the data. This is not so apparent with the
V63H/F98Y protein, showing only a minor improvement when
ﬁtting to a double hyperbola; however, the high kmax for the
high aﬃnity pathway suppresses that contribution of the low
aﬃnity pathway (at 1 mM, the lower aﬃnity pathway
represents 1.6% of the rate constant, as opposed to 22.5% for
the V63H/F42Y protein). Both the apparent KD and the kmax of
this low aﬃnity pathway have been previously shown to be
highly dependent on the nature of the reductant used,
particularly on such properties as hydrophobicity, molecular
size, and charge.9,24 This is unlike the through-protein electron
pathway that typically shows very high aﬃnity (apparent KD
value ranging in the micromolar or high nanomolar range) and
shows little eﬀect of the chemical or physical properties of the
electron-donating agent on the kmax.
9,24 The kmax values for the
Figure 1. Kinetics of ferryl Aplysia myoglobin reduction by ascorbate.
The three variants of Aplysia myoglobin, V63H (red ●), V63H/F42Y
(green ▲), and V63H/F98Y (blue ■), all in the ferryl heme state and
at 5 μM, were mixed with ascorbate (50 μM), and the kinetics of
reduction of the protein from ferryl to ferric was monitored optically.
The time courses are presented in a linear time scale (0−20 s) (A) and
logarithmic time scale (0−10 000 s) (B). Symbols represent measured
time points.
Figure 2. Pseudoﬁrst-order rate constants of 5 μM ferryl Aplysia
myoglobins reduction to the ferric form by ascorbate (panels A and B)
or CP20 (panels C and D): tyrosine-free V63H Mb variant (red ●),
V63H/F42Y Mb (green ▲), and V63H/F98Y Mb (blue ■). The rate
constants were calculated from single exponential approximations of
the time courses of the ferryl-to-ferric transformation that has been
measured spectroscopically. Panels B and D represent a detailed view
of the dependences shown in panels A and C, respectively, but on a
smaller range of the axes.
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through-protein electron transfer pathway for the V63H/F42Y
and V63H/F98Y proteins are 0.45 and 4.3 s−1, respectively,
with apparent KD values in the low micromolar range (Table
1), the KD for the V63H/F98Y protein approximately 30-fold
higher than the V63H/F42Y protein, showing that the aﬃnity
for the through-protein electron transfer pathway for the
V63H/F42Y is much higher, although at a lower kmax value
(Figure 2A and B).
The hydroxypyridinone CP20 has previously been used as a
ferryl reductant for horse Mb as the apparent KD values for the
two electron pathways are signiﬁcantly diﬀerent.24 The
tyrosine-free V63H Mb exhibits very slow reduction, with
enhanced reduction of ferryl Mb in the V63H/F42Y and
V63H/F98Y proteins (Figure 2C and D). The dependence on
CP20 concentration of the rate constant for ferryl heme
reduction in the tyrosine-free protein can be described by a
single rectangular hyperbola. The kinetics for the two tyrosine
containing proteins, however, ﬁt to double rectangular
hyperbola functions, similar to the case when ascorbate was
used. The kmax of the high aﬃnity pathway in the two tyrosine-
containing proteins is 0.45 and 4.2 s−1 for the V63H/F42Y and
V63H/F98Y proteins, respectively, essentially identical to the
kmax values with ascorbate (Table 1). The KD values for CP20
reduction via the high aﬃnity pathway are higher than those
found using ascorbate as reductant, but there is still ∼20-fold
diﬀerence between the V63H/F42Y and V63H/F98Y proteins
(Table 1). At 30 μM CP20, the rate constant for ferryl
reduction for the V63H/F42Y protein is at a maximum
diﬀerence of 1200-fold higher as compared to the V63H
protein. At 100 μM CP20, the rate constant for ferryl reduction
for the V63H/F98Y protein is 1600-fold higher as compared to
the V63H.
3.2. Changes in Protein Radical Formation as a Result
of the Through-Protein Electron Flow Pathway. Figure 3
shows the mutant Aplysia Mb EPR spectra before and after
reacting with equimolar hydrogen peroxide. The Mb samples
with no hydrogen peroxide added show similar spectra, typical
of high spin ferric heme myoglobin, with two g-values close to g
= 6 and the third value at g = 2.00. The intensities of these EPR
signals decrease on peroxide addition as the ferric heme is
oxidized to the EPR silent ferryl heme state. Accompanying this
spectral change is a moderate increase in the g = 4.28 EPR
signal, which originates from the nonheme ferric iron in a
rhombic coordination25 and is indicative of some peroxide
induced heme degradation. Furthermore, addition of H2O2 to
the Mb mutants results in formation of free radicals with the
EPR signals at g = 2.00. These signals are shown in more detail
in Figure 4A. The V63H mutant shows no appreciable free
radical formation 6 s after mixing with equimolar amount of
H2O2. In contrast, introduction of a tyrosine in position 42 or
98, in addition to the V63H mutation, allows detection of the
free radicals, although with very diﬀerent yields in the V63H/
F42Y and V63H/F98Y mutants.
Figure 4B shows the kinetic dependences of the free radicals
formed in the mutants following hydrogen peroxide addition.
No free radical is observed in the V63H protein. The time
course for the radical in the V63H/F42Y mutant shows the
radical reaches relatively high concentrations approaching 10
μM at 6 s, which constitutes 12.5% of total protein
concentration. The maximal concentration of the radicals in
the V63H/F98Y protein is signiﬁcantly lower, only 0.9 μM (at
2.97 s), which is 1.1% of the total protein concentration. The
EPR spectra used to obtain the kinetic data for the tyrosine
containing mutants (Figure 4B) are presented in Supporting
Information Figures S1 and S2. The nature of the radicals in the
two mutants is also diﬀerent as they have distinctly diﬀerent
EPR line-shapes. The V63H/F42Y EPR signal has been
simulated as a Tyr radical line-shape (Figure 5A).
Figure 4C shows the time course of the radicals in the
V63H/F42Y and V63H/F98Y proteins expressed as percentage
to the ferryl concentration. The ferryl concentration was
calculated at each time point from the measured ferric heme
concentration (Figure S3) by using the formula [ferryl](t) =
[ferric]0 − [ferric](t), where [ferric]0 = 80 μM.
3.3. Eﬀect of Electron Flow Pathways on Myoglobin-
Induced Lipid Oxidation. The increase of the rate constant
of ferryl reduction in the tyrosine-containing proteins may
aﬀect the ability of these proteins to induce lipid oxidation. To
test this hypothesis, the proteins were reacted with liposomes.
Figure 5A−C shows the extent of lipid oxidation, measured by
the formation of conjugated dienes that have an absorbance at
234 nm as a function of time. Conjugated dienes are formed,
following free radical mediated oxidation, from the rearrange-
ment of carbon double bond systems, such as the 1,4 cis−cis
pentadiene (found in unsaturated lipids like linoleate and
arachidonate).22,23 This conjugation can be used as a marker for
lipid oxidation. We used CP20 as the reductant because CP20,
in contrast to ascorbate, did not cause any signiﬁcant reduction
of the ferric Mb to the ferrous oxidation state over time scales
used for the lipid oxidation experiment. The time course for
lipid oxidation by the V63H protein is typical of Mb or Hb.
Following a lag period, a lipid oxidation cascade occurs,
showing a net increase in lipids with conjugated dienes
(measured as absorbance at 234 nm). The ability of the three
proteins in this study to oxidize lipids is not signiﬁcantly
diﬀerent, with lag periods of around 90−100 min and a
maximum rate of conjugated diene formation of around 20−30
nM s−1 (Figure 5 and Table 2). The presence of the reductant
Figure 3. EPR spectra of the Aplysia myoglobin variants in 50 mM
sodium phosphate buﬀer (pH 7.4) freeze-quenched after mixing with
either the same buﬀer or the buﬀer containing H2O2. The V63H/F42Y
+ H2O2 and V63H/F98Y + H2O2 samples were quenched 6 and 3 s,
respectively, after myoglobin was mixed with the H2O2 solution; these
time points correspond to maximal free radical concentrations (see
Figure 4). The concentrations of the proteins and peroxide were
always 80 μM after mixing. The spectra were obtained at 10 K at the
following instrumental conditions: microwave frequency νMW = 9.469
GHz, microwave power P = 3.2 mW, modulation amplitude Am = 5 G,
time constant τ = 82 ms, scan rate v = 22.6 G s−1, number of scans per
spectrum NS = 1.
Journal of the American Chemical Society Article
dx.doi.org/10.1021/ja211745g | J. Am. Chem. Soc. 2012, 134, 7741−77497745
CP20 decreases the maximal rate of lipid peroxidation with all
proteins, making the protein less eﬀective at oxidizing lipids
(Table 2). However, the decrease observed in the V63H Mb
(7.7% decrease) is not signiﬁcant (p = 0.32). The maximal rate
of lipid oxidation with the V63H/F42Y protein is signiﬁcant
(54.0% decrease, p = 0.048) as it is with the V63H/F98Y
protein (33.1% decrease, p = 0.038). The change in the lag
period, the time after addition of Mb before lipid oxidation
cascades, is also aﬀected in a similar fashion by the addition of
CP20 (Table 2). In the case of the V63H Mb, there was no
signiﬁcant change in lag period (p = 0.44), but there are
signiﬁcant changes in the cases of the variants with tyrosine in
the lag period (p = 0.065 and 0.044 for V63H/F42Y and
V63H/F98Y, respectively), thus delaying the cascade of lipid
oxidation in addition to the maximal rate of lipid oxidation.
4. DISCUSSION
The reduction of the ferryl heme iron involves electron transfer
between the reducing agent and the iron either directly or via a
through-protein electron-hopping pathway involving redox
active tyrosine residues. We used the Aplysia Mb system to
engineer these electron pathways. This approach has proved to
be an excellent platform for examination of the mechanisms
that govern such electron movements. The amino acids that are
of interest lay close to the heme pocket but are also solvent
exposed, similar to the redox active tyrosine residues in other
globins such as horse Mb (Y103) and human Hb α chain
(Y42).9,10 However, our system exhibits overall rates of
reduction of ferryl heme iron in Aplysia Mb by external
reductants much higher than those that have been observed in
Figure 4. Formation of free radicals in Aplysia myoglobin. (A) The EPR spectra of the samples of three 80 μM Aplysia Mb mutants freeze-quenched
6 s after mixing at pH 7.4 with 80 μM H2O2 (both concentrations are after mixing). The EPR spectra do not contain the g = 2 EPR signals from the
high spin ferric heme as those have been subtracted as described in the Experimental Section. Also subtracted are the “baseline” signals of the EPR
tubes or the resonator recorded for a blank sample (water). The V63H F42Y spectrum (green line) was simulated (black line) by using the
parameters given in Table S1 that have been obtained by TRSSA for the input parameters of ρC1 = 0.395 and θ = 50° (see Discussion). The V63H/
F98Y (blue line) and V63H (red line) signals are multiplied by a factor of 10. (B) Kinetic dependences of the free radicals in the course of reaction
with 80 μM peroxide for 80 μM V63H Mb (red ●), V63H/F42Y Mb (green ▲), and (V63H/F98Y) Mb (blue ■). The random error of
concentration determination was found to be between 6% and 17%. (C) The concentration of free radical for V63H/F42Y Mb (green ▲) and
V63H/F98Y Mb (blue ■) expressed as a percentage to the ferryl Mb concentration. The EPR spectra were obtained at 10 K at the following
instrumental conditions: microwave frequency νMW = 9.468 GHz, microwave power P = 0.05 mW, modulation amplitude Am = 3 G, time constant τ
= 82 ms, scan rate v = 0.60 G s−1, number of scans per spectrum NS = 1.
Figure 5. Oxidation of liposomes caused by the redox cycling of Aplysia Mb (1 μM) as measured by the formation of lipid-based conjugated dienes.
The data for the tyrosine free (A) and two tyrosine containing Mb mutants (B,C), in the absence (solid lines) and presence (dotted lines) of the
reductant CP20 (50 μM), are presented.
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other globins. These diﬀerences in electron transfer rates
cannot be explained by changes in distances.
Reduction of the ferryl state of the V63H protein, in the
absence of any tyrosines, proceeds only via direct reduction of
the heme iron by the electron-donating agent, the latter having
to gain at least partial access to the heme pocket. The two
phenylalanine residues were selected to introduce a multistep
electron hopping pathway between the heme iron and
exogenous reductants (Figure 6). In the protein, both direct
and through-protein pathways for electron transfer are evident,
observed through the double rectangular hyperbola rate
constant proﬁle (Figure 2). Introduction of tyrosine also
enhances the rate of ferryl autoreduction (Figure 2, Table 1).
This ferryl to ferric heme autoreduction has previously been
shown to be dependent on the presence of tyrosine residues,
with the autoreduction rate of sperm whale ferryl Mb being
decreased in the mutant in which all three Tyr residues were
replaced with phenylalanines.26 In this work, we show that
replacement of phenylalanines in the native protein with
tyrosines has the opposite eﬀect: the rate of the autoreduction
of the ferryl heme is signiﬁcantly increased. Such a decreased
stability of the ferryl species in Aplysia proteins containing a
tyrosine is consistent with the idea that tyrosines function as
redox cofactors, facilitating electron ﬂow to the ferryl heme
iron. Mutagenesis to remove the redox active tyrosine residues
between the radical initiation site and the distant active site of
E. coli and mouse ribonucleotide reductase R1 and R2 subunits
was eﬀective, inhibiting the activity by between 98.4% and
99.7% with single point mutations.4,27−30 Similarly, the absence
of the tyrosine in our short-range electron transfer pathway in
Aplysia Mb decreases the electron transfer rate up to 99.93%.
We have previously shown that the maximum rate constant
of direct electron transfer between the reductant and heme iron
is dependent on the chemical and physical properties of the
reductant that deﬁnes its ability to gain access to the heme
pocket. Therefore, small diﬀerences in the slope of the graphs
(Figure 2) at higher (>100 μM) reductant concentrations
between the three proteins may represent minor changes in the
accessibility of the reductant to the heme pocket arising from
the presence or absence of the tyrosine residue close to the
heme pocket. The kmax of ferryl reduction for the high aﬃnity
tyrosine-dependent electron transfer pathway has previously
been shown to be essentially independent of the physical
properties of the reductant used.9,24 This is consistent with the
data presented in Figure 2 that show the kmax for the high
aﬃnity pathway for the reduction of ferryl V63H/F42Y or
V63H/F98Y Mb by ascorbate is identical to the kmax found for
the reduction of the same protein by CP20 (Table 1).
Therefore, the maximum rate constant of electron transfer
appears to be determined by the rate-limiting step of electron
transfer between the tyrosine and heme iron. Previous results
have shown that this electron transfer rate is in the range of
0.005−0.01 s−1 for horse Mb (Y103) human α-chain Hb
(Y42).9,10,24 The addition of a tyrosine to Aplysia Mb results in
a rate of electron transfer, which is several hundreds of times
higher than in those globins. Addition of ascorbate enhances
the ferryl reduction up to 780-fold for the V63H/F42Y protein
as compared to the tyrosine free protein (at 2 μM ascorbate)
and 1310-fold for the V63H/F98Y protein (at 20 μM
ascorbate). These maximal enhancement values are even
greater with CP20 as the reductant.
We have previously remarked that the electron transfer rate
between the heme and a tyrosine ∼5 Å away (as in most
globins) should, according to the Marcus theory, be
considerably faster than observed in our ferryl heme reduction
experiments.9,24 Indeed, electron ﬂow through metalloproteins
have been demonstrated up to 20 Å distance, with electron
tunneling times in the millisecond time scale for metal-
loproteins such as Mb and cytochrome c, and projected
picosecond time scales for distances of ∼5 Å.1 Our relatively
low electron transfer rates can be explained by proposing that
only a small percentage of the protein exists in a form that can
participate in rapid transfer. This is in equilibrium with a much
more highly populated inactive state. We propose that it is only
within a subpopulation, such as [Fe4+−OH−]---Tyr−O−, with a
protonated oxoferryl and a deprotonated tyrosine, that electron
Table 2. Eﬀect of the Reductant CP20 on the Maximal Rate
of the Conjugated Diene Formation and Lag Period
protein
parameter V63H V63H/F42Y V63H/F98Y
Maximal Rate of Conjugated Diene Formation
absence of reductant
(nM s−1)
17.83 ± 1.97 27.26 ± 6.52 20.34 ± 1.01
presence of 50 μM
reductant (nM s−1)
16.46 ± 2.83 12.55 ± 2.45 13.61 ± 2.61
percentage change −7.7 −54.0 −33.1
Lag Period
absence of reductant
(min)
100.9 ± 1.3 86.1 ± 1.2 98.2 ± 15.4
presence of 50 μM
reductant (min)
99.7 ± 10.8 139.5 ± 3.8 133.4 ± 4.2
percentage change −1.25 +62.0 +35.9
Figure 6. Aplysia myoglobin structure. Highlighted are the heme (red)
and proximal histidine (white), 13 phenylalanine residues (yellow),
and two phenylalanine residues Phe42 and Phe98 replaced in the
structure ﬁle by tyrosines (green and light blue, respectively). Structure
ﬁle 1MBA33 from the Protein Data Bank (www.pdb.org/pdb) was
used to generate the ﬁgure.
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transfer occurs via a Marcus mechanism (Figure 7). This
mechanism is similar to the proton-coupled tyrosyl radical
transfer mechanism discussed in detail for ribonuclotide
reductase.3,4,31 Because the pKa values for protonated/
deprotonated states of these species are far apart (∼pH 4.5
for the ferryl8 and ∼pH 11 for the tyrosine32), the fraction of
the protein that accounts for electron transfer is minute. The
proposal that the “active” subpopulation of the proteins is in
the [Fe4+−OH−]---Tyr−O− state allows an explanation of the
observation that the maximal rate of ferryl reduction is largely
independent of pH, with the population of the “active” species
staying relatively constant. Thus, an increase in electron transfer
rate between the reductant and the heme iron of 2 orders of
magnitude, as seen in Aplysia, may reﬂect either a small shift in
the pKa for the protonation of the oxoferryl heme iron or the
deprotonation of the tyrosine. Whether the addition of a
tyrosine close to the heme changes the pKa for the protonation
of the oxyferryl heme is currently unknown. In silico virtual
mutation of the phenylalanines in positions 42 and 98 to
tyrosines shows that the closest distance between the phenyl
ring of the tyrosine and the heme ring is 5.7 Å for the V63H/
F42Y protein and 4.3 Å for the V63H/F98Y protein (Figure 6).
Thus, the diﬀerence between the kinetic parameters of ferryl
heme reduction in the V63H/F42Y and V63H/F98Y proteins
could potentially be explained by the diﬀerent proximity of the
tyrosines in these proteins to the heme. In silico mutations also
suggest that the hydroxyl group of the tyrosine residue for the
Y42 is open to the bulk solution, whereas the hydroxyl group of
Y98 is close to the protein/surface interface and may interact
with other residues through hydrogen bonding. A glutamate
(E94) residue is close (<4 Å) enough to the oxygen of Y98 to
form a hydrogen bond with only a small movement of the E94
residue (Figure S4). Thus, a hydrogen atom may be shared
between these two residues and allow easier deprotonation of
Y98, essentially shifting the pKa to a lower value and therefore
enhancing the electron transfer. The hydroxyl group of Y42,
however, can only make hydrogen bonds with water, so that
deprotonation of this residue is more diﬃcult.
The maximum yield of the radicals is very diﬀerent in the
mutants studied. It is highest in the V63H/F42Y variant, lower
in V63H/F98Y, and below detection level in the tyrosine free
mutant V63H (Figure 4). It is possible that the lower yield, and
hence stability, of the Y98 radical in V63H/F98Y is related to a
3.4 Å hydrogen bonding predicted between E94 and Y98
(Figure S4); however, with only two examples this theory
requires further testing. It should also be noted that we
previously reported formation of a free radical in the wild type
(WT) recombinant protein, also without tyrosines, when the
slow-freeze method of making EPR samples was employed.17
The maximal observable yield of that radical, tentatively
assigned to the only histidine in the protein, the proximal
histidine H95, was slightly lower than that of the V63H/F98Y
radical in the present study (0.25 vs 0.8 μM).
It is often diﬃcult to assign radicals that have unresolved or
poorly resolved EPR spectra. However, in this case, simulation
of the V63H/F42Y EPR spectrum clearly shows this to
originate from a tyrosyl radical (Figure 4A). Because there is
only one tyrosine residue in the Mb variant, the radical must be
located on this, Y42. Furthermore, the simulation determines
the ring rotation angle θ in the radical to be equal to 50.0°
(Table S1) similar to the angle (56.3°) for residue F42 in the
wild type, as determined from the crystal structure ﬁle 1MBA.33
This information both validates the TRSSA algorithm that
identiﬁes the tyrosine residue on which a radical is located and
also supports our assumption that substituting phenylalanine
for tyrosine at this location has a minor eﬀect on structure. The
EPR illustrates that these tyrosines can accommodate radicals,
the same tyrosines that are required to form a radical species for
radical migration to occur between the heme iron and the
reductant resulting in election ﬂow in the opposite direction
(Figure 7). However, it should be noted that the primary
radical generated concurrent with the ferryl (Figures 3 and 4)
may have properties diﬀerent from those of the radical
intermediate predicted to result from ferryl reduction (Figure
7). This is due to the proximity of the radical to ferryl and ferric
heme iron for the primary and proposed radical intermediate
for ferryl reduction, respectively.
The ability of Mb to oxidize liposomes is relatively
unchanged in the three mutants studied (Figure 5 and Table
2). This implies that the presence or absence of the tyrosine-
based pathway does not aﬀect the intrinsic ability of Mb to
induce lipid oxidation. Therefore, this pathway cannot on its
own promote lipid oxidation reactions. Introduction of a
reductant partial protects the liposomes from peroxidation,
decreasing the maximal rate of lipid oxidation and increasing
the lag period before lipid oxidation cascades. These eﬀects are
most likely due to the reduction of ferryl Mb before the ferryl
species is able to react with lipids. There may also be some
eﬀect from the reductants scavenging the protein radical
generated in association with ferryl heme iron. Higher levels of
conjugated diene formation in the presence of reductants do
not denote higher levels of oxidation but merely a change in the
mechanism of lipid radical attack. The degree of protection
aﬀorded by the reductant is signiﬁcantly diﬀerent in the three
proteins. Mutation of the protein to introduce the tyrosine-
based electron transfer pathway results in signiﬁcantly greater
protection to the Mb-induced lipid oxidation as compared to
the V63H protein (Figure 5 and Table 2), with the V63H/
F42Y protein showing the greatest level of protection,
Figure 7. Proposed mechanism of electron movement from an external reductant to heme iron. At neutral pH, the tyrosine and oxoferryl species are
protonated and deprotaned, respectively. A small subpopulation of [Fe4+−OH−]---Tyr−O− can be formed by deprotonation of the tyrosine (pK ≈
11) and a protonation of the oxoferryl state (pK ≈ 4.5). The protonated ferryl species is equivalent to ferric plus a radical ([FeIII−OH•]), the radical
passing to the surface tyrosine and abstracting an electron from the reductant (RH→R•). Thus, rapid electron movement from the reductant to the
heme iron occurs in a small population of the protein.
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increasing the lag period and decreasing the maximal rate of
lipid oxidation by at least 50%.
Cell-free Mb and Hb are known to participate in damaging
oxidative redox chemistry under pathological conditions.34−36
The use of modiﬁed Hb for HBOCs as potential semisynthetic
blood substitutes has failed during clinical studies. One
proposal is that oxidative damage inﬂicted by cell-free Hb is a
major cause of toxicity. This problem may be ameliorated if the
oxidative capacity of Hb could be manipulated. This study
provides proof of principle that eﬃcient tyrosine-based electron
transfer pathways may be used in the design of modiﬁed
HBOCs that cause much less oxidative damage when used in
conjunction with low concentrations of reductants.
This study conﬁrms, in a model system, that the addition of
tyrosines to speciﬁc sites on the Mb molecule can greatly
enhance the reduction of ferryl Mb by exogenously added
reductants, facilitating electron transfer between the reductant
and the ferryl heme iron and preventing lipid oxidation. While
in human Hb the elimination of the tyrosine pathway in the α
chain (Y42F) or the addition of this pathway to the β chain
(F41Y) shows the rate of electron transfer to be altered by an
order of magnitude, in the case of Aplysia Mb much larger
changes were observed.
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